Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'fiin 3'

Search results for: 'fiin 3'

Items 41-50 of 117

Page
per page
  1. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: Potassium channel inhibitor
      ≥33.45 mg/mL
  2. GlyH-101
    B1087 GlyH-101
    Target: CFTR
    Summary: CFTR Inhibitor II
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  3. MLN4924
    B1036 MLN4924
     5 Citation
    Target: NAE|Ubiquitin-activating Enzyme E1|SUMOylation
    Summary: NAE inhibitor
      ≥22.18 mg/mL
  4. Lurasidone HCl
    B1477 Lurasidone HCl
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: Dopamine D2/5-HT2A/5-HT7/5-HT1A inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.11 mg/mL
  5. Donepezil HCl
    B1602 Donepezil HCl
    Target: AChE
    Summary: AChE inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥10.4 mg/mL
  6. Hydroxyzine 2HCl
    B1549 Hydroxyzine 2HCl
    Target: Histamine H1 Receptors
    Summary: Histamine H1-receptor antagonist
  7. JNJ-7777120
    B1574 JNJ-7777120
    Target: Histamine H4 Receptors
    Summary: Histamine H4 receptor antagonist
  8. JZL184
    B1958 JZL184
    Target: MAGL
    Summary: MAGL inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  9. Mitoxantrone HCl
    B2114 Mitoxantrone HCl
    Target: Pim|Topoisomerases|USP|HIV Integrases
    Summary: Topoisomerase II inhibitor, anti-neoplastic drug
      insoluble in EtOH; ≥51.53 mg/mL
  10. Dexmedetomidine HCl
    B1357 Dexmedetomidine HCl
    Summary: Highly selective and potent alpha-2 adrenoceptor agonist
      ≥126.2 mg/mL

Items 41-50 of 117

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 112item
  2. Lab Reagents 2item
Reversibility
  1. Reversible 5item
  2. Irreversible 3item
Target
  1. Caspases 3item
  2. Cyclin-Dependent Kinases 4item
  3. Histone Deacetylases (HDACs) 2item
  4. Akt 1 item
  5. PI3K 6item
  6. CXCR 2item
  7. Raf 1 item
  8. Aurora Kinases 3item
  9. EZH2 1 item
  10. AP-1 1 item
  11. MMP 3item
  12. Peptidylprolyl isomerases 1 item
  13. DT-diaphorases 1 item
  14. MER 1 item
  15. FLT3 6item
  16. GSK-3 4item
  17. Factor Xa 1 item
  18. P-glycoprotein (P-gp) 2item
  19. PLK 1 item
  20. Chk 1 item
  21. VEGFR 7item
  22. PDGFR 7item
  23. c-Kit 2item
  24. RET 1 item
  25. Phosphodiesterases (PDEs) 1 item
  26. Hydrolase 1 item
  27. p38 1 item
  28. PKB 1 item
  29. Bcr-Abl 1 item
  30. MEK 2item
  31. FGFR 1 item
  32. Pim 1 item
  33. Liver X receptors (LXRs) 1 item
  34. Voltage-gated Sodium (NaV) Channels 1 item
  35. Deubiquitinating enzymes (DUBs) 1 item
  36. PP1 1 item
  37. PP2A 1 item
  38. Smoothened 1 item
  39. MET 1 item
  40. Src 1 item
  41. Trk Receptors 1 item
  42. STAT 1 item
  43. EGFR 2item
  44. JAK 3item
  45. Progesterone Receptors 1 item
  46. HSP90 2item
  47. CFTR 1 item
  48. Topoisomerases 3item
  49. ERK 1 item
  50. HMG-CoA Reductases 1 item
  51. c-MET 2item
  52. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  53. USP 1 item
  54. 5-HT2 Receptors 1 item
  55. LRRK2 1 item
  56. DGAT 1 item
  57. CETP 1 item
  58. D2 Receptors 1 item
  59. 5-HT1 Receptors 1 item
  60. 5-HT7 Receptors 1 item
  61. MK2 1 item
  62. 5-HT3 Receptors 1 item
  63. Angiotensin-Converting Enzymes (ACEs) 1 item
  64. Free Fatty Acid Receptors 1 item
  65. Histamine H4 Receptors 2item
  66. HIV Integrases 1 item
  67. P2X Receptors 1 item
  68. Ron 1 item
  69. Calcium-activated chloride channels (CaCC) 1 item
  70. GPR35 1 item
  71. MAGL 1 item
  72. NPY Receptors 1 item
  73. Histamine H1 Receptors 1 item
  74. Na /K ATPases 1 item
  75. Histamine H2 Receptors 1 item
  76. Phospholipases 1 item
  77. Glucocorticoid Receptors 1 item
  78. IL Receptors 1 item
  79. CCL2 1 item
  80. 15-lipoxygenases 1 item
  81. AChE 1 item
  82. Insulin Receptors 1 item
  83. IRG-1R 1 item
  84. Inward Rectifier Potassium (Kir) Channels 1 item
  85. Cdc7 1 item
  86. Adenine receptors 1 item
  87. NAE 1 item
  88. Ubiquitin-activating Enzyme E1 1 item
  89. SUMOylation 1 item
  90. ATGL 1 item
  91. PP4 1 item
  92. c-RET 1 item
  93. Protein polybromo-1 1 item
  94. SMARCA4 1 item
  95. SMARCA2 1 item
  96. HDAC 1 item
  97. human lyase 1 item
  98. IKK 1 item
  99. P97 ATPase 1 item
  100. NTPDases 1 item
  101. NOP Receptors 1 item
  102. Androgen Receptor 1 item
  103. Substance P/NK1 Receptor 1 item
  104. gp120/CD4 1 item
  105. Sirtuin 1 item
  106. CRF1 Receptors 1 item
Related Disease
  1. Acute Kidney Injury 1 item
  2. Acute Myelogenous Leukemia 1 item
  3. Acute Myeloid Leukemia 5item
  4. Bladder Cancer 1 item
  5. Breast Cancer 16item
  6. Cancer 45item
  7. Cervical Cancer 2item
  8. Colon Cancer 6item
  9. Colon Carcinoma 1 item
  10. Colorectal Cancer 9item
  11. Dyskinesia 1 item
  12. Dyslipidemia 2item
  13. Erectile Dysfunction 1 item
  14. Friedreich's Ataxia 1 item
  15. Glioblastoma 4item
  16. Glioma 3item
  17. Heart Failure 1 item
  18. HIV 2item
  19. HIV Infections 1 item
  20. Inflammatory Diseases 2item
  21. Kidney Injury Studies 1 item
  22. Leukemia 4item
  23. Lung Cancer 4item
  24. Lymphoma 3item
  25. Melanoma 4item
  26. Multiple Myeloma 2item
  27. Myelofibrosis 1 item
  28. Myeloma 1 item
  29. Narcolepsy 1 item
  30. Non-small Cell Lung Cancer 3item
  31. Non-small Cell Lung Carcinoma 1 item
  32. Ovarian Cancer 6item
  33. Pancreatic Cancer 7item
  34. Prostate Cancer 9item
  35. Psoriasis 1 item
  36. Pulmonary Fibrosis 1 item
  37. Renal Cell Carcinoma 1 item
  38. Rheumatoid Arthritis 2item
  39. Schizophrenia 2item
  40. Thyroid Cancer 1 item
  41. Type 2 Diabetes 2item